Milestones :: Perspectives :: Research
China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
National Health Commission of the People’s Republic of China [to 27 Mar 2021]
March 27: Daily briefing on novel coronavirus cases in China
On March 26, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 12 new cases of confirmed infections.
Chinese drug firm Sinovac: No vaccine-related abnormality monitored in people aged above 60
Shanghai starts vaccinating expats
Xi delivers video speech to Colombian people as Chinese vaccines arrive
Vaccinated from overseas not exempt from COVID-19 control measures
Chinese expert says COVID-19 origin research excludes lab leak, denies conflicts within WHO-China team
National Medical Products Administration – PRC [to 27 Mar 2021]
China approves clinical trials for CanSino’s inhaled COVID-19 vaccine
China’s drug authority has approved clinical tests for an inhaled COVID-19 vaccine co-developed by domestic company CanSino Biologics, the Agence France-Presse (AFP) reported on March 23.
China’s daily output of COVID-19 vaccines reaches 5m doses
The daily output of Chinese COVID-19 vaccines has reached 5 million doses, a senior official said.
Nation prepares mass domestic COVID inoculations
China had administered nearly 82.85 million doses of COVID-19 vaccine as of Tuesday as it prepares a campaign to vaccinate its entire population, the State Council’s Joint Prevention and Control Mechanism said on March 24.
Over 100 mln Chinese vaccine doses administered world wide
Over 100 million doses of COVID-19 vaccines produced by China have been administered at home and abroad, according to the State Council’s COVID-19 response inter-agency task force.